PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 20, 2026JAMA Neurology1 citations

Methodological Considerations for Quantile Aggregation in Alzheimer Disease Trials

View Full Paper
MFMichael D. FlandersMCMichelle CauncaRJRenaud La Joie

Key Points

  • The central aim is to assess the effectiveness of the quantile-aggregation method for analyzing Alzheimer disease trials.
  • Evaluated quantile-aggregation method using simulated datasets and publicly available Alzheimer's randomized trial data.
  • Identified potential advantages of the quantile-aggregation method for data analysis in Alzheimer's trials.

Abstract

This study evaluates the quantile-aggregation method using both simulated data and publicly available Alzheimer disease randomized trial data.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Flanders et al. (2026) studied this question.

synapsesocial.com/papers/6a0d4ec0f03e14405aa99eaehttps://doi.org/10.1001/jamaneurol.2026.1240
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A censored quantile transformation model for Alzheimer’s Disease data with multiple functional covariates2024
  2. 2Pooling Alzheimer's disease clinical trial data to develop personalized medicine approaches is easier said than done: A proof‐of‐principle study and call to action2024 · 1 citations
  3. 3Subgroup Analysis of a Single-Index Threshold Penalty Quantile Regression Model Based on Variable Selection2025
  4. 4Statistical considerations when estimating time‐saving treatment effects in Alzheimer's disease clinical trials2024 · 16 citations
  5. 5Statistical models for Alzheimer's disease clinical trials: Lessons learned from the DIAN-TU Platform Trial2026